SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15983390
Source:
http://linkedlifedata.com/resource/pubmed/id/15983390
Search
Subject
(
72
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0005516
,
umls-concept:C0005938
,
umls-concept:C0006142
,
umls-concept:C0023779
,
umls-concept:C0030705
,
umls-concept:C0032105
,
umls-concept:C0439234
,
umls-concept:C0543467
,
umls-concept:C0851344
,
umls-concept:C1280500
,
umls-concept:C1521801
,
umls-concept:C1521996
,
umls-concept:C1696465
pubmed:issue
22
pubmed:dateCreated
2005-7-29
pubmed:abstractText
To evaluate potential detrimental effects of exemestane on bone and lipid metabolism.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15983390-15983395
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15983390-16314656
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/15983390-16361646
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Androstadienes
,
http://linkedlifedata.com/resource/pubmed/chemical/Aromatase Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids
,
http://linkedlifedata.com/resource/pubmed/chemical/Placebos
,
http://linkedlifedata.com/resource/pubmed/chemical/exemestane
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0732-183X
pubmed:author
pubmed-author:BremnesYngveY
,
pubmed-author:EriksteinBjørnB
,
pubmed-author:GeislerJürgenJ
,
pubmed-author:HagenAnne IAI
,
pubmed-author:KragLars ELE
,
pubmed-author:LønningPer EPE
,
pubmed-author:LienErnst AEA
,
pubmed-author:MassiminiGiorgioG
,
pubmed-author:OfjordErik SES
,
pubmed-author:PaoliniJolandaJ
,
pubmed-author:PolliAnnaA
,
pubmed-author:SchlichtingEllenE
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5126-37
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15983390-Aged
,
pubmed-meshheading:15983390-Androstadienes
,
pubmed-meshheading:15983390-Aromatase Inhibitors
,
pubmed-meshheading:15983390-Bone Density
,
pubmed-meshheading:15983390-Bone Resorption
,
pubmed-meshheading:15983390-Breast Neoplasms
,
pubmed-meshheading:15983390-Double-Blind Method
,
pubmed-meshheading:15983390-Female
,
pubmed-meshheading:15983390-Humans
,
pubmed-meshheading:15983390-Lipids
,
pubmed-meshheading:15983390-Middle Aged
,
pubmed-meshheading:15983390-Placebos
,
pubmed-meshheading:15983390-Postmenopause
pubmed:year
2005
pubmed:articleTitle
Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer.
pubmed:affiliation
Section of Oncology, Department of Medicine, Haukeland University Hospital, N-5021 Bergen, Norway. per.lonning@helse-bergen.no
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study